CompletedNot Applicable

High Flow Nasal Oxygenation and Gastric Insufflation in Anesthetized Patients

South Korea45 participantsStarted 2020-11-23

Plain-language summary

Transnasal humidified rapid-insufflation ventilatory exchange(THRIVE), or also termed high flow nasal oxygenation (HFNO) is a method of supplying heated, humidified high concentrations of oxygen via nasal cavity. The purpose of this study is to investigate the effect of HFNO on gastric insufflation in paralyzed anesthetized patients undergoing laryngologic surgery.

Who can participate

Age range19 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anesthesiology physical status classification I and II * Patients scheduled for laryngeal microsurgery under general anesthesia Exclusion Criteria: * gastroesophageal reflux * gastric pathology * pregnancy * major cardiovascular, pulmonary, or cerebrovascular disease * severe obesity (body mass index\>35 kg/m2)

What they're measuring

change of gastric volume

Timeframe: before HFNO application (baseline), immediately after HFNO application

Trial details

NCT IDNCT04629911

SponsorAjou University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-24

View on ClinicalTrials.gov More Gastric Distention trials